breast cancer, AstraZeneca and FDA
FDA Approves Metastatic Breast Cancer Drug, Datroway
The FDA has approved AstraZeneca and Daiichi Sankyo’s Datroway (datopotamab deruxtecan-dlnk) to treat unresectable or metastatic hormone receptor HR+, HER2- breast cancer in adult patients who have previously received endocrine-based therapy and chemotherapy for unresectable or metastatic disease, according to a news release.
FDA Approves New ADC for HR+, HER2- Breast Cancer
The US Food and Drug Administration (FDA) has approved datopotamab deruxtecan for the treatment of certain patients with unresectable or metastatic hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer.
Beloved TV host Ananda Lewis shares her story and a message to Black women about prioritizing their health in the new year.
ZME Science on MSN6h
New AI Blood Test with Lasers Finds Breast Cancer in Its Earliest StageEven if a patient is unable to beat the disease, early-stage detection of cancer can play a crucial role in increasing their ...
It’s a sobering statistic: 1 in 8 women in the United States will be diagnosed with breast cancer during her lifetime.1 ...
The increase in breast cancer rates among younger patients is occurring as the incidence of other early-onset cancers — ...
Danielle Fishel is sharing an update about her health, saying she has completed “active cancer treatment” following her ...
BISMARCK, N.D. (Valley News Live) - A bill proposed in the North Dakota House aims to provide health coverage with no cost-sharing for additional breast screenings for individuals at greater risk for ...
"Boy Meets World" star Danielle Fishel said she is finished with radiation treatment for cancer and opened up about the side ...
From awareness to advocacy, Karen Bonds has come full circle—turning her battle into a mission to ensure that no one fights breast cancer alone.
As cancer treatment costs have increased, identifying and treating early-stage cancer sooner reduces expenses and improves ...
Riding Beyond is receiving over $30,000 in funding to address the breast cancer burden in Jackson and Josephine counties.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback